Vitremacular Adhesions and Macular Holes: Surgical and Medical Management

Sponsorship Statement: This continuing medical education activity is jointly sponsored by and

Support Statement: This activity is supported by an educational grant from

Target Audience: The intended audience for the activities is vitreoretinal specialists, comprehensive ophthalmologists, and other healthcare professionals involved in the treatment of patients with vitreoretinal disorders.

Learning Objectives: At the conclusion of this activity participants should be able to:

1. Recognize how ocular coherence tomography can assist clinicians in distinguishing, following, evaluating, and managing the clinical course of vitreomacular traction.
2. Describe common retinal diseases that may progress from an incomplete posterior vitreous detachment.
3. Apply new clinical evidence on options for management of patients with vitreomacular traction.

Course Chair:
Carmen A. Puliafito, MD, MBA
Chief Medical Editor
RetinaCME.com
Retina/Vitreous Section Editor
Ocular Surgery News^®
Dean, Keck School of Medicine
Professor of Ophthalmology
and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, California

Faculty:
Pravin U. Dugel, MD
Managing Partner
Retinal Consultants of Arizona
Phoenix, Arizona
Founding Member
Spectra Eye Institute
Sun City, Arizona
Clinical Associate Professor
Doheny Eye Institute
Keck School of Medicine
University of Southern California
Los Angeles, California

Jay S. Duker, MD
Editorial Board Member
Ocular Surgery News^®
Associate Editor, Surgical Reviews
Ophthalmic Surgery Lasers & Imaging
Director, New England Eye Center
Professor and Chairman
Department of Ophthalmology
Tufts Medical Center
Tufts University School of Medicine
Boston, Massachusetts

Peter K. Kaiser, MD
Editorial Board Member
Ocular Surgery News^®
Professor of Ophthalmology
Lerner College of Medicine
Staff, Cleveland Clinic Cole Eye Institute
Cleveland, Ohio

External Reviewer:
Ronald A. Codario, MD, FACP

Accreditation:
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Ocular Surgery News^® . Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 29, 2012 to March 28, 2013.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch and listen to the presentations, complete the posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)^TM certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Carmen A. Puliafito, MD, MBA
Grant/Research Support: Zeiss Meditec

Pravin U. Dugel, MD
Consulting Fees: Alcon Laboratories, Inc., Allergan, AMO, ArcticDx, Genentech, MacuSight, Inc., Neovista, Ora, Thrombogenics
Ownership Interest: ArcticDx, Neovista, Macusight

Jay S. Duker, MD
Research Support: Carl Zeiss Meditech, OptiVue, Topcon Medical Systems, Inc.
Scientific Advisory Board: Paloma Pharmaceuticals
Consultant: Alcon Laboratories, Inc., EMD Serono, Genentech, Merck & Co., Inc, Novartis, Ophthotech, QLT, Thrombogenics
Stock Holder: Hemera

Peter K. Kaiser, MD
Consulting Fees: Alcon Laboratories, Inc., Bayer, Genentech, Oraya, Regeneron

External Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP
No relevant financial relationships to disclose.

Vindico Medical Education and Ocular Surgery News^® staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2012 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Ocular Surgery News^® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Ocular Surgery News^® . Neither Vindico Medical Education, Ocular Surgery News^® , nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.